VYNE Therapeutics Inc(NASDAQ:VYNE) 
VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing and commercializing various therapeutics for dermatology. The company offers AMZEEQ, a topical minocycline used for the treatment of inflammatory lesions of non-nodular moderate-to-severe acne vulgaris in patients 9 years of age...
Website: http://www.vynetherapeutics.com
Founded: 2003
CEO: David Domzalski
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.62
H 1.64
L 1.54
C 1.56
V 100,095
10EMA 1.56
20EMA 1.56
60EMA 1.56
120EMA 1.56
250EMA 1.56